vaccine
-
COVID-19 Plant Extract: Clinical Trial Begins For Vaccine Made From Tobacco Plant
Scientists all over the country are testing a new two-dose COVID-19 vaccine candidate that is based on plants. Produced by Medicago vaccination, a biopharmaceutical company in Canada, the shot makes use of tobacco shrub.
Latest Research Articles
-
Scientists’ Prediction: Without a Vaccine, U.S. May Need to Endure Social Distancing Until 2022
-
WHO: At Least 70 Candidate Vaccines Against Coronavirus, Under Development
-
COVID-19: Therapy, Vaccine Show Promising Breakthrough in Israel
-
University of Pittsburgh Scientists Find Potential Coronavirus Vaccine
-
Clinical Trials of the First Novel Coronavirus Vaccine begin in the US
New Cancer Vaccine Tested 100 Percent Effective In Mice
California Doctor Skeptical Of Vaccines Put On Probation By Medical Board
This Vaccine Could Protect You From Acnes
Is it Right to Sequence DNA of Newborns? Experts Weigh in on Benefits, Consequences
WARNING: Almost Half of Men in the US have Genital HPV Infections
Scientists Have Developed an OFFICIAL Ebola Vaccine With 100-Percent Efficiency
WHO: Microcephaly-Causing Zika Virus No Longer a World Health Emergency